Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2025-02-20 Declaration of Voting R…
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'DIASORIN: COMMUNICATION ON TOTAL AMOUNT OF VOTING RIGHTS PURSUANT TO ARTICLE 85-BIS, PARAGRAPH 4-BIS, OF CONSOB REGULATION NO. 11971/1999'. It explicitly communicates the total amount of voting rights and the number of shares making up the share capital as of a specific record date (February 19, 2025). This directly relates to the structure of shareholder voting rights and capital, which falls under the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a communication about voting rights, it is not the result of a vote (like AGM results), but rather a mandatory disclosure regarding the total voting power available, which aligns best with DVA.
2025-02-20 English
Comunicazione dell'ammontare complessivo dei diritti di voto
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official communication from Diasorin, dated February 20, 2025, titled 'Comunicazione dell'ammontare complessivo dei diritti di voto' (Communication of the total amount of voting rights) pursuant to Italian CONSOB Regulation art. 85-bis, comma 4-bis. It explicitly details the total number of shares and voting rights as of a specific record date (February 19, 2025), distinguishing between ordinary shares with and without enhanced voting rights. This content directly relates to the official results or status of shareholder voting rights and capital structure as reported to the regulator. This aligns precisely with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it contains a brief company description, the core purpose is the voting rights disclosure.
2025-02-20 Italian
Diasorin S.p.A. - Pubblicazione della documentazione per l'Assemblea Straordinaria del 28 febbraio 2025
Report Publication Announcement Classification · 99% confidence The document is a formal announcement from Diasorin S.p.A. regarding the 'Pubblicazione della documentazione per l'Assemblea Straordinaria del 28 febbraio 2025' (Publication of documentation for the Extraordinary Shareholders' Meeting of February 28, 2025). The key subject is the availability of meeting documentation (Relazione Illustrativa, Domande e risposte, moduli di delega) as required by law, ahead of the meeting date. The document itself is very short (4477 characters) and explicitly states that the documentation is being made available ('sono stati messi a disposizione del pubblico'). This fits the 'MENU VS MEAL' rule, indicating it is an announcement about the availability of materials rather than the materials themselves (like AGM presentations or Proxy Statements). Since it announces the publication of documentation for a shareholders' meeting, the most appropriate classification is Report Publication Announcement (RPA), as it signals that the actual AGM/Proxy materials are now accessible.
2025-01-28 Italian
Extraordinary Shareholders' Meeting February 28, 2025 - Q&A
Proxy Solicitation & Information Statement Classification · 98% confidence The document is explicitly titled "EXTRAORDINARY SHAREHOLDERS' MEETING OF DIASORIN S.P.A. (TO BE HELD ON FEBRUARY 28, 2025) Questions and Answers". This format, presenting questions and detailed answers prepared by the company regarding matters to be voted upon at a shareholders' meeting, strongly indicates materials related to soliciting shareholder votes and providing necessary information. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). While it relates to an AGM, the content is the Q&A material prepared for the meeting, which is a core component of proxy materials, rather than the meeting presentation itself (AGM-R) or the final voting results (DVA).
2025-01-28 English
Assemblea Straordinaria degli Azionisti del 28 febbraio 2025 - Domande e risposte
AGM Information Classification · 98% confidence The document is titled "ASSEMBLEA STRAORDINARIA DEGLI AZIONISTI DI DIASORIN S.P.A. (CONVOCATA PER IL 28 FEBBRAIO 2025) Domande e Risposte" (Extraordinary Shareholders' Meeting of Diasorin S.p.A. (Convened for February 28, 2025) Questions and Answers). It explicitly states that the Q&A document was prepared pursuant to art. 127-ter, paragraph 2, Legislative Decree no. 58 (TUF), which relates to shareholder rights and information preceding a general meeting. The content discusses proposals to be voted on, specifically the enhancement of the multiple voting rights system, which is a typical topic for an AGM or related preparatory materials. Since it is a Q&A document prepared for the shareholders ahead of the meeting, it strongly aligns with the materials provided to solicit votes or inform shareholders about the meeting agenda, fitting best under Proxy Solicitation & Information Statement (PSI) or potentially AGM Information (AGM-R). Given the detailed Q&A format addressing specific proposals for the meeting, AGM-R (AGM Information) is the most precise fit for materials directly related to the meeting agenda and discussion points, although PSI is also closely related. I will select AGM-R as it directly references the Extraordinary Shareholders' Meeting.
2025-01-28 Italian
Extraordinary Shareholders' Meeting February 28, 2025 - Proxy forms pursuant art. 135-novies TUF
Proxy Solicitation & Information Statement Classification · 100% confidence The document is explicitly titled 'PROXY FORM' and details instructions for appointing a 'Designated Representative' to vote at a 'Shareholders' Meeting' (Extraordinary General Meeting of DIASORIN S.p.A. on 28 February 2025). It contains sections for shareholder details, voting instructions, and declarations related to proxy voting rights under Italian law (Legislative Decree 58/1998). This content is directly related to soliciting shareholder votes and providing the necessary documentation for participation in a general meeting, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2025-01-28 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.